Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Positive results reported in AllerVax Ragweed trials

April 26, 1996

Terramed receives patent protection for vaccine technology

April 19, 1996

CellCept available in Europe

April 19, 1996

Corixa in-licenses Optivax delivery system for vaccines

April 12, 1996

AllerVax codevelopment terminated by HMR

March 15, 1996

AI-502 slated to enter clinical trials

March 15, 1996

Axis Genetics reports on vaccine technology

March 15, 1996

T Cell Sciences, ArQule to collaborate on T cell modulators

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 16, 2025.
Atai Therapeutics discovers new 5-HT2A receptor partial agonists
BioWorld Science
Atai Therapeutics Inc. has synthesized new tetrahydro pyridine-substituted indole and azaindoles acting as 5-HT2A receptor partial agonists reported to be useful...
PHD inhibitors reported in Akebia Therapeutics patent
BioWorld Science
Akebia Therapeutics Inc. has identified new derivatives of ([1,2,4]triazolo[5,1-a]isoquinoline-5-carbonyl)glycinate acting as prolyl 4-hydroxylase (PHD) inhibitors.
FDA wants more data for Otsuka’s sNDA in PTSD
BioWorld
The U.S. FDA is insisting that another study is needed to bolster the sNDA for Rexulti (brexpiprazole) from Otsuka Pharmaceutical Co. Ltd. in treating adults with...